BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25805104)

  • 1. Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
    He HL; Lee YE; Chen HP; Hsing CH; Chang IW; Shiue YL; Lee SW; Hsu CT; Lin LC; Wu TF; Li CF
    Exp Mol Pathol; 2015 Jun; 98(3):338-45. PubMed ID: 25805104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
    He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Li CF
    Histopathology; 2015 Jun; 66(7):991-1002. PubMed ID: 25393083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of REG4 confers an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
    He HL; Lee YE; Shiue YL; Lee SW; Lin LC; Chen TJ; Wu TF; Hsing CH; Huang HY; Wang JY; Li CF
    J Surg Oncol; 2014 Dec; 110(8):1002-10. PubMed ID: 25155043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy.
    Lin CY; Hsieh PL; Chou CL; Yang CC; Lee SW; Tian YF; Shiue YL; Li WS
    Oncology; 2020; 98(8):549-557. PubMed ID: 32408308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy.
    Lee YE; He HL; Shiue YL; Lee SW; Lin LC; Wu TF; Chang IW; Lee HH; Li CF
    Tumour Biol; 2015 Sep; 36(10):7675-83. PubMed ID: 25929810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low BRCA2 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy.
    Sheu MJ; Chou CL; Yang CC; Lee SW; Tian YF; Lin CY; Hsiao SY; Chen SH; Huang WT
    Pathol Res Pract; 2020 May; 216(5):152922. PubMed ID: 32249003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy.
    Sheu MJ; Li CF; Lin CY; Lee SW; Lin LC; Chen TJ; Ma LJ
    Tumour Biol; 2014 Aug; 35(8):7755-63. PubMed ID: 24810927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High chloride channel accessory 1 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy.
    Chen TJ; He HL; Shiue YL; Yang CC; Lin LC; Tian YF; Chen SH
    Int J Med Sci; 2018; 15(11):1171-1178. PubMed ID: 30123054
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
    Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH
    J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance.
    Lin CY; Sheu MJ; Li CF; Lee SW; Lin LC; Wang YF; Chen SH
    Tumour Biol; 2014 Jul; 35(7):6823-30. PubMed ID: 24729124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of CPS1 is an independent negative prognosticator in rectal cancers receiving concurrent chemoradiotherapy.
    Lee YY; Li CF; Lin CY; Lee SW; Sheu MJ; Lin LC; Chen TJ; Wu TF; Hsing CH
    Tumour Biol; 2014 Nov; 35(11):11097-105. PubMed ID: 25099619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SERPINB5 Expression: Association with CCRT Response and Prognostic Value in Rectal Cancer.
    Chang IW; Liu KW; Ragunanan M; He HL; Shiue YL; Yu SC
    Int J Med Sci; 2018; 15(4):376-384. PubMed ID: 29511373
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.
    Lee YY; Wei YC; Tian YF; Sun DP; Sheu MJ; Yang CC; Lin LC; Lin CY; Hsing CH; Li WS; Li CF; Hsieh PL; Lin CY
    J Cancer; 2017; 8(8):1330-1337. PubMed ID: 28638446
    [No Abstract]   [Full Text] [Related]  

  • 14. High SPINK4 Expression Predicts Poor Outcomes among Rectal Cancer Patients Receiving CCRT.
    Chen TJ; Tian YF; Chou CL; Chan TC; He HL; Li WS; Tsai HH; Li CF; Lai HY
    Curr Oncol; 2021 Jun; 28(4):2373-2384. PubMed ID: 34202399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT.
    Chen HP; Chen CI; Liu KW; Chen TJ; Tian YF; Kuo YH; Li WS; Tsai HH; Wu LC; Yeh CF; Li CF; Chou CL; Lai HY
    Pathol Res Pract; 2022 Nov; 239():154158. PubMed ID: 36244249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy.
    Chen YT; Tsao SC; Tsai HP; Wang JY; Chai CY
    Virchows Arch; 2016 May; 468(5):559-67. PubMed ID: 26915033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REG3A overexpression functions as a negative predictive and prognostic biomarker in rectal cancer patients receiving CCRT.
    Li WS; Chen TJ; Lee SW; Yang CC; Tian YF; Kuo YH; Tsai HH; Wu LC; Yeh CF; Shiue YL; Chou CL; Lai HY
    Histol Histopathol; 2024 Jan; 39(1):91-104. PubMed ID: 37042618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of DSG3 in rectal adenocarcinoma treated with preoperative chemoradiotherapy.
    Chao TB; Li CF; Lin CY; Tian YF; Chang IW; Sheu MJ; Lee YE; Chan TC; He HL
    Future Oncol; 2016 Jun; 12(12):1457-67. PubMed ID: 27040321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.
    Wang HC; Chou CL; Yang CC; Huang WL; Hsu YC; Luo CW; Chen TJ; Li CF; Pan MR
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients.
    Chen TJ; Hsu BH; Lee SW; Yang CC; Tian YF; Kuo YH; Li WS; Tsai HH; Wu LC; Yeh CF; Chou CL; Lai HY
    Pathol Oncol Res; 2022; 28():1610537. PubMed ID: 36277959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.